{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:44:02Z","timestamp":1787798642339,"version":"build-2784847793"},"reference-count":56,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007555","name":"Foundation for Cardiovascular Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011948","name":"Abbott Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","structuralheartjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Structural Heart"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.shj.2025.100735","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:36:03Z","timestamp":1760002563000},"page":"100735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Left Atrial Appendage Occlusion Using the Amplatzer Amulet Device in High-Risk Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Intervention: A Randomized Pilot Study"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2443-6090","authenticated-orcid":false,"given":"Philipp","family":"Jakob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priska","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3265-4618","authenticated-orcid":false,"given":"Mi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald K.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Taramasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Paneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schuetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-4509","authenticated-orcid":false,"given":"Philipp K.","family":"Haager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1090-9213","authenticated-orcid":false,"given":"Markus","family":"Kasel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pedrazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8721-4068","authenticated-orcid":false,"given":"Thomas","family":"Pilgrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"L\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara E.","family":"St\u00e4hli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Nietlispach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.shj.2025.100735_bib1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jcin.2016.01.037","article-title":"Prevalence and impact of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the SOURCE XT prospective multicenter registry","volume":"9","author":"Tarantini","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"10.1016\/j.shj.2025.100735_bib2","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.jcin.2018.05.042","article-title":"Incidence, management, and associated clinical outcomes of new-onset atrial fibrillation following transcatheter aortic valve replacement: an analysis from the STS\/ACC TVT registry","volume":"11","author":"Vora","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"10.1016\/j.shj.2025.100735_bib3","first-page":"1285","article-title":"Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome","volume":"38","author":"Tarantini","year":"2017","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.shj.2025.100735_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jcin.2022.01.018","article-title":"New-onset atrial fibrillation after transcatheter aortic valve replacement: a systematic review and meta-analysis","volume":"15","author":"Ryan","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"10.1016\/j.shj.2025.100735_bib5","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.jcin.2020.05.049","article-title":"Valvular and nonvalvular atrial fibrillation in patients undergoing transcatheter aortic valve replacement","volume":"13","author":"Okuno","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"10.1016\/j.shj.2025.100735_bib6","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jcin.2023.07.015","article-title":"Cardiac death after transcatheter aortic valve replacement with contemporary devices","volume":"16","author":"Mesnier","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"10.1016\/j.shj.2025.100735_bib7","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.jacc.2014.08.052","article-title":"Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement","volume":"64","author":"G\u00e9n\u00e9reux","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"10.1016\/j.shj.2025.100735_bib8","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.jcin.2017.04.034","article-title":"Frequency, timing, and impact of access-site and non-access-site bleeding on mortality among patients undergoing transcatheter aortic valve replacement","volume":"10","author":"Piccolo","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.shj.2025.100735_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.shj.2025.100735_bib10","first-page":"e72","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.shj.2025.100735_bib11","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jcin.2019.06.001","article-title":"Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve replacement in patients with atrial fibrillation","volume":"12","author":"Kosmidou","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"10.1016\/j.shj.2025.100735_bib12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jcin.2017.05.005","article-title":"Antithrombotic therapy for prevention of cerebral thromboembolic events after transcatheter aortic valve replacement: evolving paradigms and ongoing directions","volume":"10","author":"Capodanno","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"Aa","key":"10.1016\/j.shj.2025.100735_bib13","doi-asserted-by":"crossref","first-page":"Aa78","DOI":"10.4244\/EIJ-D-17-00412","article-title":"Left atrial appendage occlusion","volume":"13","author":"Nietlispach","year":"2017","journal-title":"EuroIntervention"},{"issue":"13","key":"10.1016\/j.shj.2025.100735_bib14","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"15","author":"Glikson","year":"2020","journal-title":"EuroIntervention"},{"issue":"25","key":"10.1016\/j.shj.2025.100735_bib15","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.shj.2025.100735_bib16","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.shj.2025.100735_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.shj.2025.100735_bib18","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.shj.2025.100735_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jcin.2009.05.005","article-title":"Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-Year results of the PLAATO (percutaneous left atrial appendage transcatheter occlusion) study","volume":"2","author":"Block","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"issue":"30","key":"10.1016\/j.shj.2025.100735_bib20","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1093\/eurheartj\/ehaa169","article-title":"Left atrial appendage occlusion with the amplatzer\u2122 amulet\u2122 device: full results of the prospective global observational study","volume":"41","author":"Hildick-Smith","year":"2020","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.shj.2025.100735_bib21","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.4244\/EIJ-D-20-00201","article-title":"Left atrial appendage closure versus medical therapy in patients with atrial fibrillation: the APPLY study","volume":"16","author":"Gloekler","year":"2020","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.shj.2025.100735_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"Nielsen-Kudsk","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.shj.2025.100735_bib23","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/CIRCULATIONAHA.123.067312","article-title":"Concomitant left atrial appendage occlusion and transcatheter aortic valve replacement among patients with atrial fibrillation","volume":"149","author":"Kapadia","year":"2024","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.shj.2025.100735_bib24","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jcin.2016.04.038","article-title":"\"One-Stop Shop\": safety of combining transcatheter aortic valve replacement and left atrial appendage occlusion","volume":"9","author":"Attinger-Toller","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"10.1016\/j.shj.2025.100735_bib25","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.shj.2025.100735_bib26","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.7326\/M21-4653","article-title":"Left atrial appendage occlusion versus oral anticoagulation in atrial fibrillation: a decision analysis","volume":"175","author":"Chew","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.shj.2025.100735_bib27","series-title":"R: A Language and Environment for Statistical Computing: R Core Team","year":"2024"},{"issue":"1","key":"10.1016\/j.shj.2025.100735_bib28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcin.2016.10.023","article-title":"Apixaban in patients with atrial fibrillation after transfemoral aortic valve replacement","volume":"10","author":"Seeger","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"17","key":"10.1016\/j.shj.2025.100735_bib29","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.shj.2025.100735_bib30","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1161\/CIRCULATIONAHA.112.110981","article-title":"Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation","volume":"126","author":"Nombela-Franco","year":"2012","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.shj.2025.100735_bib31","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.shj.2025.100735_bib32","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1161\/STROKEAHA.124.047149","article-title":"Cerebrovascular events in patients undergoing transcatheter aortic valve replacement: a review","volume":"55","author":"Patel","year":"2024","journal-title":"Stroke"},{"issue":"23","key":"10.1016\/j.shj.2025.100735_bib33","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR","volume":"385","author":"Van Mieghem","year":"2021","journal-title":"N Engl J Med"},{"issue":"29","key":"10.1016\/j.shj.2025.100735_bib34","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/eurheartj\/ehac242","article-title":"Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial","volume":"43","author":"Collet","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.shj.2025.100735_bib35","first-page":"450","article-title":"Left-atrial appendage thrombosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation","volume":"37","author":"Stachel","year":"2021","journal-title":"Can J Cardiol"},{"issue":"7","key":"10.1016\/j.shj.2025.100735_bib36","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jacc.2016.05.069","article-title":"Feasibility of LAA closure for left atrial thrombus in patients with aortic stenosis and AF","volume":"68","author":"Parashar","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.shj.2025.100735_bib37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/CIRCINTERVENTIONS.112.000124","article-title":"Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation","volume":"6","author":"Stortecky","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"issue":"18","key":"10.1016\/j.shj.2025.100735_bib38","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jacc.2018.08.2143","article-title":"Primary hemostatic disorders and late major bleeding after transcatheter aortic valve replacement","volume":"72","author":"Kibler","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.shj.2025.100735_bib39","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.shj.2025.100735_bib40","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/j.jcin.2023.08.013","article-title":"DAPT is comparable to OAC following LAAC with WATCHMAN FLX: a national registry analysis","volume":"16","author":"Coylewright","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.shj.2025.100735_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.951943","article-title":"Predictors and neurological consequences of periprocedural cerebrovascular events following transcatheter aortic valve implantation with self-expanding valves","volume":"9","author":"Suhai","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.shj.2025.100735_bib42","first-page":"1122","article-title":"Incidence and predictors of 30-day and 6-month stroke after TAVR: insights from the multicenter OBSERVANT II study","volume":"102","author":"Gorla","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10252","key":"10.1016\/j.shj.2025.100735_bib43","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(20)31358-1","article-title":"Self-expanding intra-annular versus commercially available transcatheter heart valves in high and extreme risk patients with severe aortic stenosis (PORTICO IDE): a randomised, controlled, non-inferiority trial","volume":"396","author":"Makkar","year":"2020","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.shj.2025.100735_bib44","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1509233","article-title":"Possible subclinical leaflet thrombosis in bioprosthetic aortic valves","volume":"373","author":"Makkar","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.shj.2025.100735_bib45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcin.2017.08.015","article-title":"Long-term outcomes with transcatheter aortic valve replacement in women compared with men: evidence from a meta-analysis","volume":"11","author":"Saad","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"issue":"19","key":"10.1016\/j.shj.2025.100735_bib46","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (Amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.shj.2025.100735_bib47","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/europace\/euaa001","article-title":"Clinical outcomes of watchman vs. amplatzer occluders for left atrial appendage closure (WATCH at LAAC)","volume":"22","author":"Kleinecke","year":"2020","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.shj.2025.100735_bib48","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCULATIONAHA.121.057859","article-title":"Amulet or watchman device for percutaneous left atrial appendage closure: primary results of the SWISS-APERO randomized clinical trial","volume":"145","author":"Galea","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.shj.2025.100735_bib49","first-page":"343","article-title":"Long-term outcomes after echocardiography versus fluoroscopy-guided left atrial appendage closure: is there still a role for a simplified approach?","volume":"104","author":"Gilhofer","year":"2024","journal-title":"Catheter Cardiovasc Interv"},{"issue":"16","key":"10.1016\/j.shj.2025.100735_bib50","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jcin.2021.05.042","article-title":"Impact of echocardiographic guidance on safety and efficacy of left atrial appendage closure: an observational study","volume":"14","author":"Galea","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.shj.2025.100735_bib51","first-page":"283","article-title":"Amplatzer left atrial appendage occlusion: single center 10-year experience","volume":"82","author":"Nietlispach","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.shj.2025.100735_bib52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijcard.2020.08.070","article-title":"Comparison of fluoroscopy and transesophageal echocardiogram for intra-procedure device surveillance assessment during implantation of watchman","volume":"324","author":"Zhang","year":"2021","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.shj.2025.100735_bib53","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jcin.2023.01.011","article-title":"SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure","volume":"16","author":"Saw","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"10.1016\/j.shj.2025.100735_bib54","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion","volume":"14","author":"Della Rocca","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"22","key":"10.1016\/j.shj.2025.100735_bib55","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N Engl J Med"},{"issue":"28","key":"10.1016\/j.shj.2025.100735_bib56","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehy244","article-title":"Transcatheter aortic valve implantation: current status and future perspectives","volume":"39","author":"Cahill","year":"2018","journal-title":"Eur Heart J"}],"container-title":["Structural Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2474870625003276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2474870625003276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:59:39Z","timestamp":1773813579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2474870625003276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2474870625003276"],"URL":"https:\/\/doi.org\/10.1016\/j.shj.2025.100735","relation":{},"ISSN":["2474-8706"],"issn-type":[{"value":"2474-8706","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left Atrial Appendage Occlusion Using the Amplatzer Amulet Device in High-Risk Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Intervention: A Randomized Pilot Study","name":"articletitle","label":"Article Title"},{"value":"Structural Heart","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.shj.2025.100735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Inc. on behalf of Cardiovascular Research Foundation.","name":"copyright","label":"Copyright"}],"article-number":"100735"}}